Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers

Mandar D. Muzumdar(Harvard University), Kimberly Judith Dorans(Massachusetts Institute of Technology), Katherine Chung(Massachusetts Institute of Technology), Rebecca Robbins(Massachusetts Institute of Technology), Tuomas Tammela(Massachusetts Institute of Technology), Vasilena Gocheva(Massachusetts Institute of Technology), Carman Man-Chung Li(Massachusetts Institute of Technology), Tyler Jacks(Howard Hughes Medical Institute)
Nature Communications
September 2, 2016
Cited by 76Open Access
Full Text

Abstract

Although it has become increasingly clear that cancers display extensive cellular heterogeneity, the spatial growth dynamics of genetically distinct clones within developing solid tumours remain poorly understood. Here we leverage mosaic analysis with double markers (MADM) to trace subclonal populations retaining or lacking p53 within oncogenic Kras-initiated lung and pancreatic tumours. In both models, p53 constrains progression to advanced adenocarcinomas. Comparison of lineage-related p53 knockout and wild-type clones reveals a minor role of p53 in suppressing cell expansion in lung adenomas. In contrast, p53 loss promotes both the initiation and expansion of low-grade pancreatic intraepithelial neoplasia (PanINs), likely through differential expression of the p53 regulator p19ARF. Strikingly, lineage-related cells are often dispersed in lung adenomas and PanINs, contrasting with more contiguous growth of advanced subclones. Together, these results support cancer type-specific suppressive roles of p53 in early tumour progression and offer insights into clonal growth patterns during tumour development.


Related Papers

No related papers found

Powered by citation graph analysis